HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Flavia Lo Castro Selected Research

Migraine Disorders (Migraine)

10/2023OnabotulinumtoxinA: Still the Present for Chronic Migraine.
6/2022Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data.
3/2022Clinical Evidence of Cannabinoids in Migraine: A Narrative Review.
1/2022Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective Study.
10/2021Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study.
3/2021Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study.
11/2020Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review.
5/2020Proteomic serum profile in menstrual-related and post menopause migraine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Flavia Lo Castro Research Topics

Disease

8Migraine Disorders (Migraine)
10/2023 - 05/2020
4Headache (Headaches)
06/2022 - 05/2020
3Secondary Headache Disorders
06/2022 - 01/2021
2Pain (Aches)
01/2022 - 03/2021
1Migraine with Aura (Familial Hemiplegic Migraine)
10/2021
1Cognitive Dysfunction
03/2021
1Neuroinflammatory Diseases
05/2020
1Inflammation (Inflammations)
05/2020
1Prolactinoma (Prolactinomas)
12/2013
1Insulin Resistance
12/2013

Drug/Important Bio-Agent (IBA)

3Monoclonal AntibodiesIBA
06/2022 - 11/2020
2erenumabIBA
06/2022 - 10/2021
2Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA
06/2022 - 10/2021
2CannabinoidsIBA
03/2022 - 01/2022
1Type A Botulinum Toxins (Botox)FDA Link
10/2023
1preemptIBA
10/2023
1SuspensionsIBA
06/2022
1EndocannabinoidsIBA
03/2022
1Analgesics (Analgesic Drugs)IBA
10/2021
1Estradiol (Delestrogen)FDA LinkGeneric
03/2021
1pregnenolone sulfateIBA
03/2021
1NeurosteroidsIBA
03/2021
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
03/2021
1Pregnanolone (Allopregnanolone)IBA
03/2021
1Hormones (Hormone)IBA
03/2021
1Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
01/2021
1lasmiditanIBA
01/2021
1Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
11/2020
1Type I Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA
11/2020
1AntibodiesIBA
11/2020
1Proteins (Proteins, Gene)FDA Link
05/2020
1ProteomeIBA
05/2020
1Insulin (Novolin)FDA Link
12/2013
1Glucose (Dextrose)FDA LinkGeneric
12/2013
1ProlactinIBA
12/2013
1LipidsIBA
12/2013
1CabergolineFDA LinkGeneric
12/2013

Therapy/Procedure

1Therapeutics
10/2023